We demonstrated that miR-491-5p directly targets EGFR, CDK6, and Bcl-xL; and that miR-491-3p directly targets IGFBP2 and CDK6. Importantly, these predicted, and now confirmed targets of miR-491 each are major oncogenes in GBM. Here, CDK6 is linked to glioblastoma.